Evidence map›Paper›PMID 36826230›Full record

ArticleBrain : a journal of neurology2023

Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.

Shady Rahayel, Christina Tremblay, Andrew Vo, Bratislav Misic, Stéphane Lehéricy, Isabelle Arnulf, Marie Vidailhet, Jean-Christophe Corvol, ICEBERG Study Group, Jean-François Gagnon and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Future of Parasomnias.Journal of sleep research · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 4 countries.

Shady RahayelThe Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal H3A 2B4, Canada.ORCID 0000-0001-5786-3278
Christina TremblayThe Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal H3A 2B4, Canada.
Andrew VoThe Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal H3A 2B4, Canada.
Bratislav MisicThe Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal H3A 2B4, Canada.ORCID 0000-0003-0307-2862
Stéphane LehéricyInstitut du Cerveau-Paris Brain Institute-ICM, INSERM, CNRS, Sorbonne Université, Paris 75013, France.
Isabelle ArnulfInstitut du Cerveau-Paris Brain Institute-ICM, INSERM, CNRS, Sorbonne Université, Paris 75013, France.ORCID 0000-0002-2240-2516
Marie VidailhetInstitut du Cerveau-Paris Brain Institute-ICM, INSERM, CNRS, Sorbonne Université, Paris 75013, France.
Jean-Christophe CorvolInstitut du Cerveau-Paris Brain Institute-ICM, INSERM, CNRS, Sorbonne Université, Paris 75013, France.
ICEBERG Study Group
Jean-François GagnonCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal H4J 1C5, Canada.
Ronald B PostumaCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal H4J 1C5, Canada.
Jacques MontplaisirCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal H4J 1C5, Canada.
Simon LewisForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown NSW 2050, Australia.ORCID 0000-0002-4093-7071
Elie MatarForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown NSW 2050, Australia.ORCID 0000-0002-4994-0488
Kaylena Ehgoetz MartensForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Camperdown NSW 2050, Australia.
Per BorghammerDepartment of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus DK-8200, Denmark.
Karoline KnudsenDepartment of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus DK-8200, Denmark.
Allan K HansenDepartment of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus DK-8200, Denmark.
Oury MonchiResearch Centre, Institut universitaire de gériatrie de Montréal, Montreal H3W 1W5, Canada.
Ziv Gan-OrThe Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal H3A 2B4, Canada.ORCID 0000-0003-0332-234X
Alain DagherThe Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal H3A 2B4, Canada.ORCID 0000-0002-0945-5779
Alzheimer’s Disease Neuroimaging Initiative
Centre National de la Recherche Scientifique · FRMontreal Neurological Institute and Hospital · CAThe University of Sydney · AUAarhus University Hospital · DKUniversité du Québec à Montréal · CAInstitut du Cerveau · FRMontreal General Hospital · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson's disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49-87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41-88) years; 77% men] with T1-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain's structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer's disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain's structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer's disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks.

Indexed as

Alzheimer DiseaseREM Sleep Behavior DisorderSynucleinopathiesAtrophyCerebral Cortical ThinningFemaleHumansMaleMitochondriadementia with Lewy bodiesMRInetwork analysisParkinson’s diseaseREM sleep behaviour disordertranscriptomics

Identifiers

PMID36826230
PMCPMC10393413
OpenAlexW4321749735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.